NL123338C - - Google Patents

Info

Publication number
NL123338C
NL123338C NL123338DA NL123338C NL 123338 C NL123338 C NL 123338C NL 123338D A NL123338D A NL 123338DA NL 123338 C NL123338 C NL 123338C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL123338C publication Critical patent/NL123338C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
NL123338D 1961-12-08 NL123338C (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1429161 1961-12-08

Publications (1)

Publication Number Publication Date
NL123338C true NL123338C (es)

Family

ID=4399594

Family Applications (2)

Application Number Title Priority Date Filing Date
NL286444D NL286444A (es) 1961-12-08
NL123338D NL123338C (es) 1961-12-08

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL286444D NL286444A (es) 1961-12-08

Country Status (6)

Country Link
US (1) US3247063A (es)
BE (1) BE643068A (es)
FR (1) FR2227M (es)
GB (1) GB997727A (es)
NL (2) NL123338C (es)
SE (1) SE327253B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3548052A (en) * 1964-10-27 1970-12-15 Canada Packers Ltd Heparin compositions and methods of using same
US3482014A (en) * 1966-06-29 1969-12-02 Canada Packers Ltd Orally active heparin and method for making and using same
US3546338A (en) * 1967-03-30 1970-12-08 American Cyanamid Co Heparin composition
US3444093A (en) * 1968-01-29 1969-05-13 Burton Parsons Chemicals Inc Self-mixing anticoagulant composition
US3903266A (en) * 1972-05-03 1975-09-02 Ralph C Robbins Compositions and methods for disaggregating blood cells
US4098995A (en) * 1976-07-12 1978-07-04 American Cyanamid Company Polygalactosido-sucrose poly(h-)sulfate salts
US4021544A (en) * 1976-07-12 1977-05-03 American Cyanamid Company Complement inhibitors
US4188188A (en) * 1978-09-27 1980-02-12 Bio-Rad Laboratories, Inc. High density lipoprotein cholesterol assay
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US5668116A (en) * 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5145841A (en) * 1987-03-19 1992-09-08 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions
FR2622450B1 (fr) * 1987-11-03 1991-02-22 Sanofi Sa Association heparine/dermatane sulfate
GB8826448D0 (en) * 1988-11-11 1988-12-14 Thrombosis Res Inst Improvements in/relating to organic compounds
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid

Also Published As

Publication number Publication date
BE643068A (es) 1964-05-15
GB997727A (en) 1965-07-07
US3247063A (en) 1966-04-19
SE327253B (es) 1970-08-17
FR2227M (fr) 1963-12-23
NL286444A (es)

Similar Documents

Publication Publication Date Title
BE620770A (es)
BE601393A (es)
BE601844A (es)
BE626029A (es)
NL123338C (es)
BE625787A (es)
BE629892A (es)
BE625064A (es)
BE601042A (es)
BE601041A (es)
BE600983A (es)
BE624621A (es)
BE396226A (es)
BE624470A (es)
BE600841A (es)
BE600768A (es)
BE623891A (es)
BE623666A (es)
BE622698A (es)
BE622208A (es)
BE600667A (es)
BE620900A (es)
BE600261A (es)
BE458606A (es)
BE620809A (es)